Article Information
PubMed
History
- Published online December 19, 2023.
Copyright & Usage
© 2023 CMA Impact Inc. or its licensors This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/
Author Information
- Nicole Le Saux, MD,
- Julie Bettinger, PhD,
- Hennady P. Shulha, PhD,
- Manish Sadarangani, BM BCh,
- Doug Coyle, PhD,
- Timothy F. Booth, PhD,
- Taj Jadavji, MD,
- Scott A. Halperin, MD,
- For members of Immunization Monitoring Program Active
- Children’s Hospital of Eastern Ontario (CHEO) (Le Saux), University of Ottawa, Ottawa, Ont.; Vaccine Evaluation Center, BC Children’s Hospital Research Institute (Bettinger, Shulha, Sadarangani), University of British Columbia, Vancouver, BC; School of Epidemiology and Public Health (Coyle), University of Ottawa, Ottawa, Ont.; Viral Diseases Division, National Microbiology Laboratory (Booth), Public Health Agency of Canada, Winnipeg, Man.; Alberta Children’s Hospital (Jadavji), University of Calgary, Alta.; Dalhousie University and Canadian Center for Vaccinology (Halperin), IWK Health Centre, Halifax, NS
- Correspondence to: Nicole Le Saux, lesaux{at}cheo.on.ca
Funding
Public Health Agency of Canada, the Canadian Paediatric Society
GSK Pharmaceuticals and Merck Canada